Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $7.6 million.

  • Korro Bio's Cash from Investing Activities rose 16039.12% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year increase of 12152.54%. This contributed to the annual value of -$123.3 million for FY2024, which is 120486.38% down from last year.
  • As of Q3 2025, Korro Bio's Cash from Investing Activities stood at $7.6 million, which was up 16039.12% from -$11.3 million recorded in Q2 2025.
  • Over the past 5 years, Korro Bio's Cash from Investing Activities peaked at $32.8 million during Q1 2025, and registered a low of -$102.4 million during Q2 2024.
  • For the 5-year period, Korro Bio's Cash from Investing Activities averaged around -$7.3 million, with its median value being -$3.4 million (2023).
  • In the last 5 years, Korro Bio's Cash from Investing Activities tumbled by 289219.75% in 2024 and then soared by 68422.74% in 2025.
  • Korro Bio's Cash from Investing Activities (Quarter) stood at -$14.6 million in 2021, then surged by 130.63% to $4.5 million in 2022, then crashed by 136.88% to -$1.7 million in 2023, then crashed by 67.07% to -$2.8 million in 2024, then skyrocketed by 374.72% to $7.6 million in 2025.
  • Its last three reported values are $7.6 million in Q3 2025, -$11.3 million for Q2 2025, and $32.8 million during Q1 2025.